Specialist Letter - CDA Implementation Guide v1.3

Name
NEHTA-0966:2012 Specialist Letter - CDA Implementation Guide v1.3
Identifier
NEHTA-0966:2012
Version
1.3
Date
07-03-2012

This document provides a guide to implementing the 'logical' model detailed by the Agency's Specialist Letter Structured Content Specification as an HL7 Clinical Document Architecture Release 2 (CDA) XML document. The primary aim of the guide is to take implementers step by step through the mapping of each data component of the structured content specification to a corresponding CDA attribute or element. The resulting CDA document would be used for the electronic exchange of specialist letters between healthcare providers. This guide also presents conformance requirements, against which implementers can attest the conformance of their systems.

This specification references or contains excerpts of intellectual property (IP) owned by the Regenstrief Institute, IHTSDO, or HL7 International. Applicable IP constraints apply:

  • This material contains content from LOINCTM (http://loinc.org). The LOINC table, LOINC codes, and LOINC panels and forms file are copyright © 1995-2015, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and available at no cost under the license at http://loinc.org/terms-of-use. LOINC is a trademark of Regenstrief Institute, Inc., registered in the United States.
  • This material includes SNOMED Clinical TermsTM (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO, (http://www.ihtsdo.org).
  • This document includes excerpts of HL7TM International standards and other HL7 International material. HL7 International is the publisher and holder of copyright in the excerpts. The publication, reproduction and use of such excerpts is governed by the HL7 IP Policy (see http://www.hl7.org/legal/ippolicy.cfm) and the HL7 International License Agreement. HL7 and CDA are trademarks of Health Level Seven International and are registered with the United States Patent and Trademark Office.